Stockscreener 앱 받기
29.71
0.87%
-0.26
Alkermes Plc 주식(ALKS)의 최신 뉴스
Expansion Therapeutics Names Elliot Ehrich, MD, Chief Medical Officer - Marketscreener.com
Alkermes pays off and terminates major credit agreement By Investing.com - Investing.com Canada
2025 will be a big year for Mural Oncology's drugs in development - The Business Journals
Alkermes pays off and terminates major credit agreement - Investing.com
Tidal Investments LLC Invests $1.10 Million in Alkermes plc (NASDAQ:ALKS) - MarketBeat
Alkermes Prepares for New Flexibility Post Credit Termination - TipRanks
Geode Capital Management LLC Sells 60,037 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat
We Think Alkermes (NASDAQ:ALKS) Can Stay On Top Of Its Debt - Simply Wall St
Wilmington Savings Fund Society FSB Invests $582,000 in Alkermes plc (NASDAQ:ALKS) - MarketBeat
Barclays PLC Boosts Holdings in Alkermes plc (NASDAQ:ALKS) - MarketBeat
Alkermes To Take Part In The Fourth Annual Evercore ISI Healthconx Conference - Environmental Expert
Opioid Use Disorder Market: Share, Key Trends, Growth Drivers, - openPR
When (ALKS) Moves Investors should Listen - Stock Traders Daily
Fmr LLC Has $9.71 Million Stake in Alkermes plc (NASDAQ:ALKS) - MarketBeat
State Street Corp Lowers Stake in Alkermes plc (NASDAQ:ALKS) - MarketBeat
Alkermes plc (NASDAQ:ALKS) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Alkermes' EVP Craig Hopkinson sells shares worth $1.96 million By Investing.com - Investing.com South Africa
Frazier Life Sciences Management L.P. Acquires New Stake in Alkermes plc (NASDAQ:ALKS) - MarketBeat
Alkermes director Cato Laurencin sells $85,708 in stock By Investing.com - Investing.com Canada
Alkermes' EVP Craig Hopkinson sells shares worth $1.96 million - Investing.com
Wellington Management Group LLP Sells 1,696,507 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat
Alkermes plc (NASDAQ:ALKS) Stake Lifted by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat
Insider Sell: Craig Hopkinson Sells 9,221 Shares of Alkermes PLC (ALKS) - GuruFocus.com
Alkermes' chief medical officer sells $290,461 in stock By Investing.com - Investing.com Australia
Alkermes' chief medical officer sells $290,461 in stock - Investing.com India
Insider Sell: Craig Hopkinson Sells 14,349 Shares of Alkermes PL - GuruFocus.com
RTW Investments LP Sells 402,955 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat
BNP Paribas Financial Markets Buys 63,939 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat
Alkermes EVP and chief medical officer sells shares worth $441,550 By Investing.com - Investing.com Canada
Alkermes EVP and chief medical officer sells shares worth $441,550 - Investing.com
Alkermes PLC (ALKS) Shares Up 4.58% on Dec 4 - GuruFocus.com
Drug Addiction Treatment Market Future Business Opportunities - openPR
Citigroup Inc. Buys 65,536 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat
Charles Schwab Investment Management Inc. Has $58.98 Million Stock Position in Alkermes plc (NASDAQ:ALKS) - MarketBeat
Public Sector Pension Investment Board Reduces Position in Alkermes plc (NASDAQ:ALKS) - MarketBeat
Fisher Asset Management LLC Acquires 18,147 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat
Alkermes plc (NASDAQ:ALKS) Stock Position Reduced by Connor Clark & Lunn Investment Management Ltd. - MarketBeat
Insider Sell: Christian Nichols Sells Shares of Alkermes PLC - GuruFocus.com
Alkermes SVP Nichols sells $151,813 in stock By Investing.com - Investing.com Nigeria
Alkermes SVP Nichols sells $151,813 in stock - Investing.com India
Pathstone Holdings LLC Has $2 Million Stake in Alkermes plc (NASDAQ:ALKS) - MarketBeat
Natixis Advisors LLC Increases Position in Alkermes plc (NASDAQ:ALKS) - MarketBeat
Axsome Therapeutics eyes approval after Phase III narcolepsy win - Clinical Trials Arena
Loomis Sayles & Co. L P Purchases 1,478,422 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat
Intech Investment Management LLC Buys New Shares in Alkermes plc (NASDAQ:ALKS) - MarketBeat
Alkermes to Participate in Upcoming Investor Conferences - StreetInsider.com
Alkermes: Products Sales, ALKS 2680 Can Still Drive Long-Term Growth - Seeking Alpha
Eagle Asset Management Inc. Trims Holdings in Alkermes plc (NASDAQ:ALKS) - MarketBeat
Victory Capital Management Inc. Grows Position in Alkermes plc (NASDAQ:ALKS) - MarketBeat
1.61%
1.65%
자본화:
|
볼륨(24시간):